Literature DB >> 2029211

Scleroderma and survival.

A J Silman1.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 2029211      PMCID： PMC1004401          DOI： 10.1136/ard.50.4.267

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  19 in total

1.  Prognostic significance of Raynaud's phenomenon and other clinical characteristics of systemic scleroderma. A study of 271 cases.

Authors:  R G FARMER; R W GIFFORD; E A HINES
Journal:  Circulation       Date:  1960-06       Impact factor: 29.690

2.  The prognosis of systemic sclerosis.

Authors:  N R Rowell
Journal:  Br J Dermatol       Date:  1976-07       Impact factor: 9.302

3.  Progressive systemic sclerosis in the elderly.

Authors:  J A Dalziel; G K Wilcock
Journal:  Postgrad Med J       Date:  1979-03       Impact factor: 2.401

4.  Scleroderma in the elderly, with special reference to the CRST syndrome.

Authors:  H M Hodkinson
Journal:  J Am Geriatr Soc       Date:  1971-03       Impact factor: 5.562

5.  Malignancy in progressive systemic sclerosis--association with breast carcinoma.

Authors:  P Lee; C Alderdice; S Wilkinson; E C Keystone; M B Urowitz; D D Gladman
Journal:  J Rheumatol       Date:  1983-08       Impact factor: 4.666

6.  Cancer and systemic sclerosis. An epidemiologic study.

Authors:  A D Roumm; T A Medsger
Journal:  Arthritis Rheum       Date:  1985-12

7.  Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis.

Authors:  M Giordano; G Valentini; S Migliaresi; U Picillo; M Vatti
Journal:  J Rheumatol       Date:  1986-10       Impact factor: 4.666

8.  Incidence of lung cancer in systemic sclerosis.

Authors:  M Peters-Golden; R A Wise; M Hochberg; M B Stevens; F M Wigley
Journal:  J Rheumatol       Date:  1985-12       Impact factor: 4.666

9.  Progressive systemic sclerosis in Auckland: a ten year review with emphasis on prognostic features.

Authors:  R J Eason; P L Tan; P J Gow
Journal:  Aust N Z J Med       Date:  1981-12

10.  Scleroderma (progressive systemic sclerosis): progress and course based on a personal series of 118 cases.

Authors:  A J Barnett
Journal:  Med J Aust       Date:  1978-08-12       Impact factor: 7.738
View more
  5 in total

1.  Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis.

Authors:  C P Simeon; L Armadans; V Fonollosa; M Vilardell; J Candell; C Tolosa; F Mearin; M J Rodrigo; R Solans; J Lima; G Sampol
Journal:  Ann Rheum Dis       Date:  1997-12       Impact factor: 19.103

2.  Significance of palpable tendon friction rubs in early diffuse cutaneous systemic sclerosis.

Authors:  Adam Doré; Mary Lucas; Dana Ivanco; Thomas A Medsger; Robyn T Domsic
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-08       Impact factor: 4.794

3.  Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosis.

Authors:  Robyn T Domsic; Svetlana I Nihtyanova; Stephen R Wisniewski; Michael J Fine; Mary Lucas; C Kent Kwoh; Christopher P Denton; Thomas A Medsger
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

4.  Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study.

Authors:  Eric Hachulla; Patrick Carpentier; Virginie Gressin; Elisabeth Diot; Yannick Allanore; Jean Sibilia; David Launay; Luc Mouthon; Patrick Jego; Jean Cabane; Pascal de Groote; Amélie Chabrol; Isabelle Lazareth; Loïc Guillevin; Pierre Clerson; Marc Humbert
Journal:  Rheumatology (Oxford)       Date:  2009-01-27       Impact factor: 7.580

5.  Whole-genome bisulfite sequencing in systemic sclerosis provides novel targets to understand disease pathogenesis.

Authors:  Tianyuan Lu; Kathleen Oros Klein; Inés Colmegna; Maximilien Lora; Celia M T Greenwood; Marie Hudson
Journal:  BMC Med Genomics       Date:  2019-10-24       Impact factor: 3.063
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.